Pathophysiology of chronic heart failure

The Lancet

Volumn 340, Issue 8811, 1992, Pages 88-92

  Packer, M ^a  

^a ADDRESS: Division of Circulatory Physiology Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

ANGIOTENSIN II; CATECHOLAMINES; CHRONIC DISEASE; ENERGY METABOLISM; HEART FAILURE, CONGESTIVE; HEMODYNAMICS; HUMAN; MYOCARDIAL CONTRACTION; NEUROSECRETORY SYSTEMS; SODIUM; VASOCONSTRICTION;

EID: 0026694353     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90405-R     Document Type: Article

References (35)

1. Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle
2. Reversible and irreversible elongation of ischemic, infarcted, and healed myocardium in response to increases in preload and afterload
3. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches
4. Baroreceptor function in congestive heart failure: effect on neurohormonal activation and regional vascular resistance
5. Sympathoinhibitory effects of atrial natriuretic factor in normal humans
6. Effects of atrial natriuretic peptide on renal arterioles: morphologic analysis using microvascular cells
7. Ventricular remodelling induced severe myocardial dysfunction in the aging rat heart
8. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment
9. Arterial baroreflex abnormalities in heart failure: reversal after orthotopic cardiac transplantation
10. Response of atrial natriuretic factor to acute and chronic increases of atrial pressure in experimental heart failure in dogs: role of changes in heart rate, atrial dimensions, and cardiac tissue concentration
11. β-adrenergic pathways in nonfailing and failing human ventricular myocardium
12. Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and β-adrenergic receptors in congestive heart failure and reversal with angiotensin converting-enzyme-inhibitor therapy
13. i-proteins in heart failure
14. Pacing-induced heart failure in the dog: evaluation of peripheral vascular α-adrenoceptor subtypes
15. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system
16. Increased endothelin in experienced heart failure
17. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in heart failure
18. Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion
19. Endothelium-dependent vasodilation is attenuated in patients with heart failure
20. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease
21. Limb vascular responsiveness to β-adrenergic receptor stimulation in patients with congestive heart failure
22. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure
23. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system
24. Renal interaction between the sympathetic and ANP in rats with chronic ischemic heart failure
25. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure
26. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure
27. Adrenergic effects on the biology of the adult mammalian cardiocyte
28. Cardiac myocyte necrosis induced by angiotensin II
29. Nebivolol increases survival in cardiomyopathic hamsters with congestive heart failure
30. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril
31. Oxygen free radicals and congestive heart failure
32. Elevated circulating levels of tumor necrosis factor in congestive heart failure
33. Interleukin- 1 and tumour necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness
34. Leukocyte-dependent and leukocyte-independent mechanisms of impairment of endothelium-mediated vasodilatation
35. Circulating tumor necrosis factor and endothelial-derived relaxing factor in severe heart failure